Details of the Drug Formulaction

General Information of Drug Formulation (ID: F03083)

• Formulation Name: Cabozantinib 20 mg capsule
• Company: Exelixis

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Cabozantinib	(DMIYDT4)	Medullary thyroid gland carcinoma		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Ammonia	(E00007)	222	Alkalizing agent
Butyl alcohol	(E00011)	263	Flavoring agent; Solvent
Carmellose sodium	(E00625)	Not Available	Disintegrant
Ferrosoferric oxide	(E00231)	14789	Colorant
Isopropyl alcohol	(E00070)	3776	Antimicrobial preservative; Solvent
Propylene glycol	(E00040)	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Stearic acid	(E00079)	5281	Emulsifying agent; Solubilizing agent; Viscosity-controlling agent; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent